Creative Medical Technology Holdings Inc
Research Creative Medical Technology Holdings Inc (CELZ) on Bullrun: market cap USD 4.58M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerCELZ
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryBiotechnology
- CurrencyUSD
- Market capUSD 4.58M
- Financial periodQ1 2026
- RevenueUSD 3.00K
- Net income-USD 1.41M
- Free cash flow-USD 1.45M
- Gross margin66.9%
Valuation Snapshot
latest market cap is USD 4.58M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 6.00K | -USD 6.00M | -USD 5.86M | 63.4% | -2.52 | USD 7.21M | n/a | USD 7.51M |
| FY2024 | USD 11.00K | -USD 5.49M | -USD 5.50M | 60.0% | -3.71 | USD 5.94M | n/a | USD 6.34M |
| FY2023 | USD 9.00K | -USD 5.29M | n/a | 60.0% | -3.76 | USD 3.47M | n/a | USD 10.34M |
| FY2022 | USD 88.60K | -USD 10.14M | n/a | 67.8% | -0.93 | USD 8.32M | n/a | USD 15.86M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-25 | USD 4.58M | n/a | n/a | n/a |
| 2025 | 2025-12-31 | USD 7.25M | n/a | n/a | n/a |
| 2024 | 2024-12-31 | USD 4.04M | n/a | n/a | n/a |
| 2023 | 2023-12-29 | USD 6.37M | n/a | n/a | n/a |
| 2022 | 2022-12-30 | USD 5.36M | n/a | n/a | n/a |
| 2021 | 2021-12-31 | USD 14.01M | 0.3 | n/a | n/a |
About Creative Medical Technology Holdings Inc
Creative Medical Technology Holdings, Inc., a commercial-stage biotechnology company, focuses on novel biological therapeutics in the fields of immunotherapy, endocrinology, urology, neurology, and orthopedics in the United States. The company offers CaverStem to treat erectile dysfunction, and FemCelz for the treatment of loss of genital sensitivity and dryness.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Creative Medical Technology Holdings Inc's market cap?
Creative Medical Technology Holdings Inc's market capitalization is USD 4.58M.
What does Creative Medical Technology Holdings Inc do?
Creative Medical Technology Holdings, Inc., a commercial-stage biotechnology company, focuses on novel biological therapeutics in the fields of immunotherapy, endocrinology, urology, neurology, and orthopedics in the United States. The company offers CaverStem to treat erectile dysfunction, and FemCelz for the treatment of loss of genital sensitivity and dryness.